O'Shaughnessy Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.9M Buy
144,588
+12,202
+9% +$4.35M 0.25% 80
2025
Q4
$43.3M Buy
132,386
+27,035
+26% +$8.58M 0.24% 85
2025
Q3
$29.7M Buy
105,351
+4,250
+4% +$1.23M 0.17% 122
2025
Q2
$28.2M Sell
101,101
-2,926
-3% -$829K 0.19% 109
2025
Q1
$32.4M Buy
104,027
+24,719
+31% +$7.3M 0.26% 81
2024
Q4
$20.7M Sell
79,308
-5,429
-6% -$1.61M 0.18% 123
2024
Q3
$27.5M Buy
84,737
+6,728
+9% +$2.2M 0.25% 80
2024
Q2
$24.4M Buy
78,009
+10,846
+16% +$3.19M 0.25% 85
2024
Q1
$19.1M Sell
67,163
-33,842
-34% -$9.9M 0.21% 103
2023
Q4
$29.1M Sell
101,005
-39,443
-28% -$10.7M 0.39% 59
2023
Q3
$37.7M Sell
140,448
-73,163
-34% -$18.3M 0.56% 36
2023
Q2
$47.4M Sell
213,611
-58,288
-21% -$13.5M 0.7% 22
2023
Q1
$65.7M Buy
271,899
+3,363
+1% +$826K 1.03% 11
2022
Q4
$70.5M Buy
268,536
+31,658
+13% +$8.49M 1.15% 7
2022
Q3
$53.4M Buy
236,878
+16,096
+7% +$3.9M 1% 10
2022
Q2
$53.7M Buy
220,782
+3,656
+2% +$896K 0.99% 15
2022
Q1
$52.5M Buy
217,126
+13,476
+7% +$3.1M 0.87% 20
2021
Q4
$45.8M Buy
203,650
+18,157
+10% +$3.83M 0.81% 25
2021
Q3
$39.4M Buy
185,493
+85,018
+85% +$19.6M 0.81% 27
2021
Q2
$24.5M Buy
100,475
+67,671
+206% +$16.6M 0.49% 58
2021
Q1
$8.16M Buy
32,804
+6,393
+24% +$1.53M 0.18% 122
2020
Q4
$6.07M Sell
26,411
-160,963
-86% -$37.1M 0.17% 112
2020
Q3
$47.6M Sell
187,374
-185,440
-50% -$45.9M 1.43% 19
2020
Q2
$88M Sell
372,814
-78,680
-17% -$18M 2.73% 6
2020
Q1
$91.6M Sell
451,494
-132,671
-23% -$29M 3.21% 2
2019
Q4
$141M Sell
584,165
-24,698
-4% -$5.44M 3.13% 4
2019
Q3
$118M Sell
608,863
-5,722
-0.9% -$1.1M 2.8% 4
2019
Q2
$113M Sell
614,585
-3,331
-0.5% -$596K 2.64% 5
2019
Q1
$117M Buy
617,916
+46,561
+8% +$8.89M 2.79% 4
2018
Q4
$111M Buy
571,355
+114,855
+25% +$22.4M 2.81% 5
2018
Q3
$94.3M Buy
456,500
+366,027
+405% +$72.1M 1.93% 14
2018
Q2
$16.7M Buy
90,473
+81,623
+922% +$14.4M 0.35% 65
2018
Q1
$1.51M Sell
8,850
-58
-0.7% -$10.6K 0.03% 208
2017
Q4
$1.55M Sell
8,908
-245
-3% -$43.4K 0.04% 225
2017
Q3
$1.71M Sell
9,153
-6,495
-42% -$1.15M 0.04% 222
2017
Q2
$2.69M Buy
15,648
+4,387
+39% +$714K 0.06% 177
2017
Q1
$1.85M Buy
+11,261
New +$1.87M 0.04% 218
2014
Q1
Sell
-5,635
Closed -$643K 973
2013
Q4
$643K Sell
5,635
-274,181
-98% -$31.2M 0.01% 393
2013
Q3
$31.3M Sell
279,816
-78,131
-22% -$8.47M 0.75% 38
2013
Q2
$35.4M Buy
+357,947
New +$37.1M 0.94% 29

Other funds holding AMGN

O'Shaughnessy Asset Management's AMGN Position: Q1 2026 in Review

O'Shaughnessy Asset Management increased its Amgen (AMGN) stake by 9.2% in Q1 2026, buying an estimated $4.35M and bringing the position to 144,588 shares worth $50.9M. The position accounts for 0.25% of the portfolio, ranked #80.

O'Shaughnessy Asset Management first reported a position in AMGN in Q2 2013 and has held it in 40 quarters since. The position peaked at $141M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • O'Shaughnessy Asset Management held 144,588 shares of Amgen worth $50.9M as of Q1 2026.
  • O'Shaughnessy Asset Management bought 12,202 Amgen shares in Q1 2026, an estimated $4.35M.
  • Amgen made up 0.25% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #80 holding.
  • O'Shaughnessy Asset Management first reported a position in Amgen in Q2 2013 and has held it in 40 quarters since.
  • O'Shaughnessy Asset Management's Amgen position peaked at $141M in Q4 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.